- Home
- PMEC vs IXHL Comparison
PMEC vs IXHL Comparison
Compare PMEC & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMEC
- IXHL
- Stock Information
- Founded
- PMEC 1984
- IXHL 2001
- Country
- PMEC Singapore
- IXHL Australia
- Employees
- PMEC N/A
- IXHL N/A
- Industry
- PMEC
- IXHL
- Sector
- PMEC
- IXHL
- Exchange
- PMEC Nasdaq
- IXHL Nasdaq
- Market Cap
- PMEC 56.9M
- IXHL 49.1M
- IPO Year
- PMEC 2023
- IXHL N/A
- Fundamental
- Price
- PMEC $1.60
- IXHL $0.38
- Analyst Decision
- PMEC
- IXHL
- Analyst Count
- PMEC 0
- IXHL 0
- Target Price
- PMEC N/A
- IXHL N/A
- AVG Volume (30 Days)
- PMEC 137.8K
- IXHL 28.1M
- Earning Date
- PMEC 01-01-0001
- IXHL 11-14-2025
- Dividend Yield
- PMEC N/A
- IXHL N/A
- EPS Growth
- PMEC N/A
- IXHL N/A
- EPS
- PMEC N/A
- IXHL N/A
- Revenue
- PMEC $74,349,000.00
- IXHL $86,000.00
- Revenue This Year
- PMEC N/A
- IXHL $1,188.37
- Revenue Next Year
- PMEC N/A
- IXHL N/A
- P/E Ratio
- PMEC N/A
- IXHL N/A
- Revenue Growth
- PMEC 2.52
- IXHL 616.67
- 52 Week Low
- PMEC $0.54
- IXHL $0.08
- 52 Week High
- PMEC $2.44
- IXHL $3.12
- Technical
- Relative Strength Index (RSI)
- PMEC 37.62
- IXHL 45.03
- Support Level
- PMEC $1.58
- IXHL $0.34
- Resistance Level
- PMEC $2.30
- IXHL $0.41
- Average True Range (ATR)
- PMEC 0.21
- IXHL 0.03
- MACD
- PMEC -0.05
- IXHL 0.01
- Stochastic Oscillator
- PMEC 2.51
- IXHL 47.69
About PMEC Primech Holdings Ltd.
Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.